“Improving Translational Research in Poland – A Roundtable Session”
“Strengthening Cancer Controls in Poland – A Workshop”

Concept for the Roundtable and Workshop:

  • Focus:

First Day (November 18) – Roundtable Session: Joint examination by Polish, American and other Europeans of subjects for translational research that are or mutual importance.

Second Day (November 19) – Workshop: Poland’s priorities on improving cancer control planning for cancer research, treatment and prevention with examples from American and other European experience.

  • Timing: Poland’s upcoming national elections make this autumn a logical time for a review of cancer control planning and associated advances in translational research.
  • Scope: The scope will be limited in the number of subjects to permit a substantive examination of each subject presented during the Workshop and Roundtable.
  • Participation: The Roundtable and Workshop will include a senior group of Poles, Americans and other experts. Follow-on actions will expand support and expertise for the outcomes from both events.

Approach:

  • Structure: The Senior Level Roundtable for translational research and Workshop for cancer control planning will accomplish three tasks:
    1. Examination of selected subjects for improvement in translational research and cancer control planning.
    2. Identification of improvements for further development and implementation following these two events.
    3. Agreement on instructions for a report of the Workshop and the Roundtable results and other Follow-on actions.

Note: Follow-on actions will be considered to develop the improvements identified during the Roundtable and Workshop into more detailed proposals, and will be sized according to available resources.

  • Proposed Subjects covering 2 Day Period for the Roundtable and Workshop:

Roundtable Session for Improving Translational Research in Poland:

    • Academic clinical studies with focus on early stage.
    • Clinical and translational registry studies.
    • Immunotherapy with emphasis on contributions to implementing cell therapy (i.e. CAR) at the Oncology Institute in Warsaw.
    • Other subjects to be determined.

Workshop for Strengthening Cancer Controls in Poland:

    • Cancer control plan development in Poland.
    • Monitoring of cancer preventive actions.
    • Oncology rehabilitation.
    • Rare cancers.
    • Guidelines development.
    • Immunotherapy
    • Other subjects to be determined.
  • Outcomes: Identification of:
    • Key actions addressing subjects for translational research of importance in Poland and of mutual interest to Americans and other Europeans.
    • Changes in selected cancer controls in Poland with emphasis on cancer prevention and improved treatment outcomes.

Administration and Organization:

  • Administration:
    • Organizers: The Roundtable Session and the Workshop will be organized by the Alliance for Innovation (AFI) in partnership with the Maria Sklodowska-Curie Institute of Oncology, Ministry of Health and Medical Research Agency.
    • Endorsers: The following organizations will be invited to endorse these two events: the US National Cancer Institute, the Polish Medical Research Agency, the National Comprehensive Cancer Network, the Polish Society for Clinical Oncology, the American Society of Clinical Oncology, the MD Anderson Cancer Center, the Massey Cancer Center at the Virginia Commonwealth University, and the US Centers for Disease Control and Prevention.
  • Organization of the Roundtable Session and Workshop:
    • Dates: The Roundtable Session will be held on November 18, 2019. The Workshop will be held on November 19, 2019.
    • Location: Both events will be held in Warsaw at the Maria Sklodowska-Curie Institute of Oncology.
    • Participants: Each of the two events will be planned for 25 to 30 senior health care leaders from Poland and experts from the US and other selected countries.
    • Supporting Actions: Small supporting meetings will be held before and after these two events.
    • Follow-on: Actions will be undertaken by those interested organizations represented at the Workshop and the Roundtable as permitted by available resources.
  • Resources: Resources will be required for the following:
    • Preparation for the Roundtable the Workshop – Organization and Logistics.
    • Management of the Roundtable and Workshop – Roundtable Session, Workshop and associated meetings.
    • Follow-on – Report and coordination of the development of more detailed descriptions of improvements to cancer controls.

Milestones:

  • August-Early September: Agreement on date, agenda (to include specific areas and subjects for examination), participants and venue.
  • September: Invitation to speakers and other participants.
  • October: Finalize speakers, agenda, venue and participants. Coordinate plan for Roundtable and Workshop reports and Follow-on.
  • November: Roundtable on November 18 and Workshop on November 19.
  • December: Report of Workshop and Roundtable results and other Follow-on actions.
  • Dates to be Determined: Complete Follow-on actions.

Agenda:

10:00 – 10:10 Opening remarks: Jan Walewski and George Handy
10:10 – 10:40 Introductory presentations
Maria Skłodowska Curie Institute of Oncology – Cancer Center – Jan Walewski – Director
UVA Cancer Center Thomas P. Loughran, Jr. MD – Director
National Comprehensive Cancer Network – CEO Dr Bob Carlson
10:40 – 11:15 Prevention (3 min presentations)
Dr Melina Davis (a slide presentation)
Prof. Joanna Didkowska, Dr Bernard Fuemmeler, Prof. Magdalena Bielska-Lasota, Prof. Michał Kamiński, Prof.
Jan Poleszczuk, Dr Bozena Cybulska Stopa
Discussion (10 min)
11:15 – 11:40 Basic/preclinical research (3 min presentations)
Prof. Michał Mikula, Prof. Przemysław Juszczyński, Prof. Janusz Siedlecki, Prof. Zygmunt Pojda, Prof.
Magdalena Chechlińska, Dr Tomasz Stokłosa, Prof. Monika Prochorec-Sobieszek
Discussion (10 min)
11:40 – 12:00 Coffee break
12:00 – 12:25 Clinical research – general oncology (3 min presentations)
Prof Steven Grant (a slide presentation)
Prof. Iwona Ługowska, Prof. Rafał Dziadziuszko, Dr Dorota Kiprian, Prof. Renata Duchnowska, Prof. Anna
Raciborska
Discussion (10 min)
12:25 – 12:50 Clinical research – cancer specific oncology (3 min presentations)
Prof. Anna Czarnecka, Prof. Mariusz Bidziński, Prof. Radosław Mądry, Prof. Tomasz Mandat, Prof. Marek
Dedecjus, Prof. Romuald Krajewski
Discussion (10 min)
12:50 – 13:05 Clinical research – cancer specific oncology (3 min presentations)
Prof. Paweł Wiechno/dr Jakub Kucharz, Prof. Maciej Krzakowski/dr Adam Płużański, Prof. Jan Walewski, Dr.
Peter Wiernik, Dr. Grzegorz Nowakowski, Dr. Beata Jagielska
Discussion (10 min)
13:05-14:00 Working lunch
14:00-15:00 Discussion on how to implement identified projects: funding, logistics, formalities (10 min
presentations)
US funds – Dr Jose Morey
Medical Research Agency – Radosław Sierpiński
Polish public funds – Agnieszka Janowska
Private funds – Robert Lugowski
Discussion (10 min)
15:00-15:30 Wrap up and next steps summary – Jan Walewski and George Handy